Rickets: Clinical Trials

13 trials for Rickets, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed. 13 Phase 1, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 113Completed 13
Phase 28Completed 8

Follow Rickets: new trials by email Literature Review of Rickets trials Research Report on Rickets

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of Age
Burosumab - X-linked Hypophosphatemia (XLH)
Phase 1 / Phase 2CompletedKyowa Kirin Pharmaceutical Development Ltd162020-02-262024-11-07
Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia
68Ga-DOTATATE PET/CT - Osteomalacia
Phase 1 / Phase 2CompletedMayo Clinic182019-01-312025-04-30
A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia
KRN23 - X-linked Hypophosphatemic Rickets/Osteomalacia
Phase 1CompletedKyowa Kirin Co., Ltd.152014-07-012017-03-03
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
KRN23 - X-linked Hypophosphatemia
Phase 1 / Phase 2CompletedKyowa Kirin Co., Ltd.232012-02-012024-06-18
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
KRN23 - X-linked Hypophosphatemia
Phase 1 / Phase 2CompletedKyowa Kirin Co., Ltd.292011-04-012024-06-18
A Study of KRN23 in X-linked Hypophosphatemia
Placebo, KRN23 - X-linked Hypophosphatemia
Phase 1CompletedKyowa Kirin Co., Ltd.422008-12-012024-06-17
Safety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP)
asfotase alfa - Hypophosphatasia (HPP)
Phase 1 / Phase 2CompletedAlexion Pharmaceuticals, Inc.112008-09-012019-04-01
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Asfotase Alfa - Hypophosphatasia (HPP)
Phase 1CompletedAlexion Pharmaceuticals, Inc.62008-08-012019-03-29
The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients
Niacinamide, Placebo - Hyperphosphatemia
Phase 1 / Phase 2CompletedWashington University School of Medicine172006-10-012007-07-30
The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients
Niacinamide - Hyperphosphatemia
Phase 1CompletedWashington University School of Medicine402006-04-012009-01-16
Growth Hormone Treatment in Children With Hypophosphatemic Rickets
norditropine simplex - X Linked Hypophosphatemic Rickets
Phase 1 / Phase 2CompletedBicetre Hospital192006-01-012016-03-28
Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets
Cinacalcet - Hypophosphatemic Rickets, X-Linked Dominant
Phase 1CompletedChildren's Mercy Hospital Kansas City82005-06-012021-01-19
Nursing-Home Residents Given Bread Fortified With Vitamin D3
Bread fortified with vitamin D3 and calcium - Vitamin D Deficiency, Low Bone Density
Phase 1 / Phase 2CompletedUniversity of Toronto452004-11-012008-11-13

Narrower conditions

Familial Hypophosphatemic Rickets (7)  ·  Osteomalacia (5)  ·  Bone Diseases (2)  ·  Chronic Kidney Disease-Mineral and Bone Disorder (2)  ·  Hyperphosphatemia (2)  ·  Hypophosphatasia (2)  ·  Kidney Failure, Chronic (2)  ·  Bone Diseases, Metabolic (1)  ·  Osteoporosis (1)  ·  Vitamin D Deficiency (1)

Broader conditions

Avitaminosis (13)  ·  Calcium Metabolism Disorders (13)  ·  Deficiency Diseases (13)  ·  Malnutrition (13)  ·  Metabolic Diseases (13)  ·  Musculoskeletal Diseases (13)  ·  Nutrition Disorders (13)  ·  Nutritional and Metabolic Diseases (13)  ·  Bone Diseases, Metabolic (12)  ·  Vitamin D Deficiency (12)  ·  Bone Diseases (11)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9)  ·  Female Urogenital Diseases (9)  ·  Female Urogenital Diseases and Pregnancy Complications (9)

Interventions

burosumab (5)  ·  Niacinamide (2)  ·  asfotase alfa (2)  ·  Calcium (1)  ·  Cholecalciferol (1)  ·  Cinacalcet (1)  ·  Growth Hormone (1)

Sponsors

Kyowa Kirin Co., Ltd. (4)  ·  Alexion Pharmaceuticals, Inc. (2)  ·  Washington University School of Medicine (2)  ·  Bicetre Hospital (1)  ·  Children's Mercy Hospital Kansas City (1)  ·  Kyowa Kirin Pharmaceutical Development Ltd (1)  ·  Mayo Clinic (1)  ·  University of Toronto (1)

Countries

United States (9)  ·  Canada (4)  ·  United Kingdom (2)  ·  Austria (1)  ·  France (1)  ·  Italy (1)  ·  Japan (1)  ·  South Korea (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Arab Emirates (1)

Top investigators

Amy Zhang, PhD (2)  ·  Daniel O Young, MD (1)  ·  Daniel W Coyne, M.D> (1)  ·  Matthew Drake, MD (1)  ·  Rachel Levy-Olomucki, MD (1)  ·  Stephen M Broski, MD (1)  ·  Thomas O. Carpenter, M.D. (1)

Results publications

PMID 25919461, PMID 40576086, PMID 18385391, PMID 19244376, PMID 19776051, PMID 22397652, PMID 24120120, PMID 24569459, PMID 26073451, PMID 26529632, PMID 28822957, PMID 32762706, PMID 39151033, PMID 42044650